We care about rare.

Especially when it impacts lives.

We believe rare diseases deserve a different approach:

  • One that understands the patient journey
  • One that accelerates diagnoses
  • One that addresses treatment frustrations
  • One that delivers answers that doctors, patients, and care partners continue to search for

We believe treating and living with a rare disease should feel a little more "common."
And that’s why we nourish rare disease brands in a different way.

Calcium+Company has extensive experience in rare diseases.

4

rare disease launches
within the last 2 years

3

partnerships with
leading rare disease
advocacy groups

8

full-time PhDs and MDs
on staff with rare disease
experience

14

current rare disease
brands supported within
Calcium+Company

of Calciumites have experience in rare disease products

Lamzede logo
Gavreto logo
Odomzo logo
Rozlytrek logo
Briviact logo
Zynyz logo
Fintepla logo
Revcovi logo
Zilbrysq logo
Alecensa logo
Rystiggo logo
Nayzilam logo
Elfabrio logo

Case study: Award-winning DSE

THE SITUATION: There was a lack of comprehensive information regarding both Fabry disease and what effective management looks like.

OUR ROLE: We spearheaded a comprehensive disease education campaign—Rethink Fabry—to challenge misconceptions, increase understanding and identification of Fabry, and foster a sense of community and hope for both patients and HCPs. We also helped uncover a key misperception that women were only carriers of Fabry and not patients.

THE RESULT: Rethink Fabry has become a hub of resources to which the entire Fabry community can flock to find information, and countless women now have the tools they need to identify a disease that’s been disregarded for too long.

Case study: Launching with big impact

THE SITUATION: In the alpha-mannosidosis space—an area with no specific advocacy groups and a lack of specialists—we recognized the need to create dialogue and a supportive community.

OUR ROLE: We championed the development of powerful creative and messaging to demonstrate how Lamzede enables small but measurable differences in patients’ and their loved ones’ daily lives.

THE RESULT: Increased recognition and identification of more patients than ever anticipated.

Meet Julie, our rare disease specialist.

Julie Moss SVP, Global Client Lead

WHY CALCIUM: By focusing on rare diseases, we can truly impact the lives of those who may otherwise be overlooked. I joined this company because of our shared passion for making a difference. Our work not only brings hope to those affected by rare diseases but also drives innovation and progress in the field of medicine.

RARE FACT: Did you know that there are more than 7,000 known rare diseases, and approximately 95% of them have no FDA-approved treatment?

We believe no disease is too rare to care about.

To find out more, contact Greg Lewis:
[email protected]908.625.5753